Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8194 USD | -2.53% | +1.29% | -26.18% |
03-15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Business Summary
Number of employees: 186
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
CytoSorb
85.3
%
| 29 | 82.4 % | 31 | 85.3 % | +8.55% |
Grant
14.5
%
| 5 | 15.4 % | 5 | 14.5 % | -1.21% |
Other
0.2
%
| 1 | 2.3 % | 0 | 0.2 % | -91.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other Countries
49.7
%
| 16 | 45.6 % | 18 | 49.7 % | +14.08% |
Germany
35.7
%
| 13 | 36.2 % | 13 | 35.7 % | +3.17% |
United States
14.7
%
| 6 | 18.2 % | 5 | 14.7 % | -15.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Vincent Capponi
PSD | President | 66 | 24/04/02 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Chief Tech/Sci/R&D Officer | 55 | 30/04/20 | |
Steven Sisk
CTO | Chief Tech/Sci/R&D Officer | - | 17/08/15 |
Edward Jones
BRD | Director/Board Member | 75 | 31/03/07 |
James Komsa
PRN | Corporate Officer/Principal | - | 10/01/21 |
Corporate Officer/Principal | - | 14/04/13 | |
Sales & Marketing | - | 12/08/12 | |
General Counsel | 69 | 16/01/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 13/07/15 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Edward Jones
BRD | Director/Board Member | 75 | 31/03/07 |
Alan Sobel
BRD | Director/Board Member | 63 | 12/11/14 |
Jiny Kim
BRD | Director/Board Member | 47 | 31/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,306,415 | 49,213,952 ( 90.62 %) | 0 | 90.62 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.18% | 45.66M | |
+7.62% | 219B | |
+6.70% | 183B | |
+11.94% | 132B | |
+24.60% | 106B | |
-2.66% | 62.09B | |
+4.81% | 50.88B | |
+11.55% | 50.8B | |
-1.09% | 40.64B | |
+26.82% | 31.59B |
- Stock Market
- Equities
- CTSO Stock
- Company Cytosorbents Corporation